US Agency Broadens Coverage Of Personalis Breast Cancer Test - Personalis (NASDAQ:PSNL)

Personalis wins expanded Medicare coverage for NeXT Personal MRD test in breast cancer patients undergoing neoadjuvant therapy.

Raccontata dabenzinga.com